These results using chemical inhibitors showed that between MEK-ERK and PI3K pathways, only the MEK-ERK pathway is involved in the increase in CXCR4 expression in HeyA8 ovarian cancer cells. The gene discussed is MAPK1; the disease is ovarian cancer.